Global H7N9 Vaccines Market Research Report 2024

Report ID: 1912332 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 H7N9 Vaccines Market Overview
    1.1 Product Overview and Scope of H7N9 Vaccines
    1.2 H7N9 Vaccines Segment by Type
        1.2.1 Global H7N9 Vaccines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 H7N9 Split Vaccine
        1.2.3 H7N9 Live Attenuated Vaccine
        1.2.4 Others
    1.3 H7N9 Vaccines Segment by Application
        1.3.1 Global H7N9 Vaccines Sales Comparison by Application: (2022-2028)
        1.3.2 Treatment
        1.3.3 Research Institutions
    1.4 Global H7N9 Vaccines Market Size Estimates and Forecasts
        1.4.1 Global H7N9 Vaccines Revenue 2017-2028
        1.4.2 Global H7N9 Vaccines Sales 2017-2028
        1.4.3 H7N9 Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 H7N9 Vaccines Market Competition by Manufacturers
    2.1 Global H7N9 Vaccines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global H7N9 Vaccines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global H7N9 Vaccines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers H7N9 Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 H7N9 Vaccines Market Competitive Situation and Trends
        2.5.1 H7N9 Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest H7N9 Vaccines Players Market Share by Revenue
        2.5.3 Global H7N9 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H7N9 Vaccines Retrospective Market Scenario by Region
    3.1 Global H7N9 Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global H7N9 Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America H7N9 Vaccines Market Facts & Figures by Country
        3.3.1 North America H7N9 Vaccines Sales by Country
        3.3.2 North America H7N9 Vaccines Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe H7N9 Vaccines Market Facts & Figures by Country
        3.4.1 Europe H7N9 Vaccines Sales by Country
        3.4.2 Europe H7N9 Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific H7N9 Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific H7N9 Vaccines Sales by Region
        3.5.2 Asia Pacific H7N9 Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America H7N9 Vaccines Market Facts & Figures by Country
        3.6.1 Latin America H7N9 Vaccines Sales by Country
        3.6.2 Latin America H7N9 Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa H7N9 Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa H7N9 Vaccines Sales by Country
        3.7.2 Middle East and Africa H7N9 Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global H7N9 Vaccines Historic Market Analysis by Type
    4.1 Global H7N9 Vaccines Sales Market Share by Type (2017-2022)
    4.2 Global H7N9 Vaccines Revenue Market Share by Type (2017-2022)
    4.3 Global H7N9 Vaccines Price by Type (2017-2022)
5 Global H7N9 Vaccines Historic Market Analysis by Application
    5.1 Global H7N9 Vaccines Sales Market Share by Application (2017-2022)
    5.2 Global H7N9 Vaccines Revenue Market Share by Application (2017-2022)
    5.3 Global H7N9 Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Novavax
        6.1.1 Novavax Corporation Information
        6.1.2 Novavax Description and Business Overview
        6.1.3 Novavax H7N9 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Novavax H7N9 Vaccines Product Portfolio
        6.1.5 Novavax Recent Developments/Updates
    6.2 Beijing Tiantan Biological Products
        6.2.1 Beijing Tiantan Biological Products Corporation Information
        6.2.2 Beijing Tiantan Biological Products Description and Business Overview
        6.2.3 Beijing Tiantan Biological Products H7N9 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Beijing Tiantan Biological Products H7N9 Vaccines Product Portfolio
        6.2.5 Beijing Tiantan Biological Products Recent Developments/Updates
    6.3 Hualan Bio
        6.3.1 Hualan Bio Corporation Information
        6.3.2 Hualan Bio Description and Business Overview
        6.3.3 Hualan Bio H7N9 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Hualan Bio H7N9 Vaccines Product Portfolio
        6.3.5 Hualan Bio Recent Developments/Updates
    6.4 Sinovac
        6.4.1 Sinovac Corporation Information
        6.4.2 Sinovac Description and Business Overview
        6.4.3 Sinovac H7N9 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sinovac H7N9 Vaccines Product Portfolio
        6.4.5 Sinovac Recent Developments/Updates
    6.5 North Carolina Biotechnology
        6.5.1 North Carolina Biotechnology Corporation Information
        6.5.2 North Carolina Biotechnology Description and Business Overview
        6.5.3 North Carolina Biotechnology H7N9 Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 North Carolina Biotechnology H7N9 Vaccines Product Portfolio
        6.5.5 North Carolina Biotechnology Recent Developments/Updates
7 H7N9 Vaccines Manufacturing Cost Analysis
    7.1 H7N9 Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of H7N9 Vaccines
    7.4 H7N9 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 H7N9 Vaccines Distributors List
    8.3 H7N9 Vaccines Customers
9 H7N9 Vaccines Market Dynamics
    9.1 H7N9 Vaccines Industry Trends
    9.2 H7N9 Vaccines Market Drivers
    9.3 H7N9 Vaccines Market Challenges
    9.4 H7N9 Vaccines Market Restraints
10 Global Market Forecast
    10.1 H7N9 Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of H7N9 Vaccines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of H7N9 Vaccines by Type (2023-2028)
    10.2 H7N9 Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of H7N9 Vaccines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of H7N9 Vaccines by Application (2023-2028)
    10.3 H7N9 Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of H7N9 Vaccines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of H7N9 Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global H7N9 Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million)
    Table 2. Global H7N9 Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million)
    Table 3. Global H7N9 Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global H7N9 Vaccines Market Competitive Situation by Manufacturers in 2021
    Table 5. Global H7N9 Vaccines Sales (K Dose) of Key Manufacturers (2017-2022)
    Table 6. Global H7N9 Vaccines Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global H7N9 Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global H7N9 Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market H7N9 Vaccines Average Price (USD/Dose) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers H7N9 Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers H7N9 Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global H7N9 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H7N9 Vaccines as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global H7N9 Vaccines Sales by Region (2017-2022) & (K Dose)
    Table 16. Global H7N9 Vaccines Sales Market Share by Region (2017-2022)
    Table 17. Global H7N9 Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global H7N9 Vaccines Revenue Market Share by Region (2017-2022)
    Table 19. North America H7N9 Vaccines Sales by Country (2017-2022) & (K Dose)
    Table 20. North America H7N9 Vaccines Sales Market Share by Country (2017-2022)
    Table 21. North America H7N9 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America H7N9 Vaccines Revenue Market Share by Country (2017-2022)
    Table 23. Europe H7N9 Vaccines Sales by Country (2017-2022) & (K Dose)
    Table 24. Europe H7N9 Vaccines Sales Market Share by Country (2017-2022)
    Table 25. Europe H7N9 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe H7N9 Vaccines Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific H7N9 Vaccines Sales by Region (2017-2022) & (K Dose)
    Table 28. Asia Pacific H7N9 Vaccines Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific H7N9 Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific H7N9 Vaccines Revenue Market Share by Region (2017-2022)
    Table 31. Latin America H7N9 Vaccines Sales by Country (2017-2022) & (K Dose)
    Table 32. Latin America H7N9 Vaccines Sales Market Share by Country (2017-2022)
    Table 33. Latin America H7N9 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America H7N9 Vaccines Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa H7N9 Vaccines Sales by Country (2017-2022) & (K Dose)
    Table 36. Middle East and Africa H7N9 Vaccines Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa H7N9 Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa H7N9 Vaccines Revenue Market Share by Country (2017-2022)
    Table 39. Global H7N9 Vaccines Sales by Type (2017-2022) & (K Dose)
    Table 40. Global H7N9 Vaccines Sales Market Share by Type (2017-2022)
    Table 41. Global H7N9 Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global H7N9 Vaccines Revenue Share by Type (2017-2022)
    Table 43. Global H7N9 Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 44. Global H7N9 Vaccines Sales (K Dose) by Application (2017-2022)
    Table 45. Global H7N9 Vaccines Sales Market Share by Application (2017-2022)
    Table 46. Global H7N9 Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global H7N9 Vaccines Revenue Share by Application (2017-2022)
    Table 48. Global H7N9 Vaccines Price by Application (2017-2022) & (USD/Dose)
    Table 49. Novavax Corporation Information
    Table 50. Novavax Description and Business Overview
    Table 51. Novavax H7N9 Vaccines Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 52. Novavax H7N9 Vaccines Product
    Table 53. Novavax Recent Developments/Updates
    Table 54. Beijing Tiantan Biological Products Corporation Information
    Table 55. Beijing Tiantan Biological Products Description and Business Overview
    Table 56. Beijing Tiantan Biological Products H7N9 Vaccines Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 57. Beijing Tiantan Biological Products H7N9 Vaccines Product
    Table 58. Beijing Tiantan Biological Products Recent Developments/Updates
    Table 59. Hualan Bio Corporation Information
    Table 60. Hualan Bio Description and Business Overview
    Table 61. Hualan Bio H7N9 Vaccines Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 62. Hualan Bio H7N9 Vaccines Product
    Table 63. Hualan Bio Recent Developments/Updates
    Table 64. Sinovac Corporation Information
    Table 65. Sinovac Description and Business Overview
    Table 66. Sinovac H7N9 Vaccines Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 67. Sinovac H7N9 Vaccines Product
    Table 68. Sinovac Recent Developments/Updates
    Table 69. North Carolina Biotechnology Corporation Information
    Table 70. North Carolina Biotechnology Description and Business Overview
    Table 71. North Carolina Biotechnology H7N9 Vaccines Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 72. North Carolina Biotechnology H7N9 Vaccines Product
    Table 73. North Carolina Biotechnology Recent Developments/Updates
    Table 74. Production Base and Market Concentration Rate of Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. H7N9 Vaccines Distributors List
    Table 77. H7N9 Vaccines Customers List
    Table 78. H7N9 Vaccines Market Trends
    Table 79. H7N9 Vaccines Market Drivers
    Table 80. H7N9 Vaccines Market Challenges
    Table 81. H7N9 Vaccines Market Restraints
    Table 82. Global H7N9 Vaccines Sales Forecast by Type (2023-2028) & (K Dose)
    Table 83. Global H7N9 Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 84. Global H7N9 Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 85. Global H7N9 Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 86. Global H7N9 Vaccines Sales Forecast by Application (2023-2028) & (K Dose)
    Table 87. Global H7N9 Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 88. Global H7N9 Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 89. Global H7N9 Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 90. Global H7N9 Vaccines Sales Forecast by Region (2023-2028) & (K Dose)
    Table 91. Global H7N9 Vaccines Sales Market Share Forecast by Region (2023-2028)
    Table 92. Global H7N9 Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 93. Global H7N9 Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of H7N9 Vaccines
    Figure 2. Global H7N9 Vaccines Market Share by Type in 2021 & 2028
    Figure 3. H7N9 Split Vaccine Product Picture
    Figure 4. H7N9 Live Attenuated Vaccine Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global H7N9 Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Treatment
    Figure 8. Research Institutions
    Figure 9. Global H7N9 Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global H7N9 Vaccines Market Size (2017-2028) & (US$ Million)
    Figure 11. Global H7N9 Vaccines Sales (2017-2028) & (K Dose)
    Figure 12. H7N9 Vaccines Sales Share by Manufacturers in 2021
    Figure 13. Global H7N9 Vaccines Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest H7N9 Vaccines Players: Market Share by Revenue in 2021
    Figure 15. H7N9 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global H7N9 Vaccines Sales Market Share by Region (2017-2022)
    Figure 17. Global H7N9 Vaccines Sales Market Share by Region in 2021
    Figure 18. Global H7N9 Vaccines Revenue Market Share by Region (2017-2022)
    Figure 19. Global H7N9 Vaccines Revenue Market Share by Region in 2021
    Figure 20. U.S. H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Taiwan H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Philippines H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Vietnam H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. U.A.E H7N9 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of H7N9 Vaccines by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of H7N9 Vaccines
    Figure 46. Manufacturing Process Analysis of H7N9 Vaccines
    Figure 47. H7N9 Vaccines Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novavax
Beijing Tiantan Biological Products
Hualan Bio
Sinovac
North Carolina Biotechnology
Frequently Asked Questions
H7N9 Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
H7N9 Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
H7N9 Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports